Drug Approval

NATCO receives CDSCO approval for Semaglutide in India

Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus

NATCO Pharma Limited received approval for Semaglutide from Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide Injection in India. NATCO will launch the product in the India market in March’26.

Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.

Upcoming E-conference

Other Related stories

Zydus receives final approval from USFDA for Ammonium Lactate Cream, 12%

FDA nod to Acrotech's new eczema treatment

FDA refuses to file Moderna’s seasonal flu vaccine application, citing comparator issue

Interviews

Only 4-5 I

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 I

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Companies

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Appointments

Merck KGaA’s Belen Garijo to become CEO of Sanofi

Merck KGaA’s Belen Garijo to become CEO of Sanofi

Dr. David Berman to Join Moderna as Chief Development Officer

Dr. David Berman to Join Moderna as Chief Development Officer

Yugap Wellness bolsters scientific leadership with Dr Satish Singh appointment

Yugap Wellness bolsters scientific leadership with Dr Satish Singh appointment

Startup

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups

EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Digitization

WuXi Biologics launches PatroLab digital twin platform to transform biologics manufacturing

WuXi Biologics launches PatroLab digital twin platform to transform biologics manufacturing

Thermo Fisher and NVIDIA team up to supercharge labs with AI

Thermo Fisher and NVIDIA team up to supercharge labs with AI

Revvity and Lilly partner to accelerate AI drug discovery models

Revvity and Lilly partner to accelerate AI drug discovery models

Latest Stories

Torrent Pharmaceuticals posts Rs. 577 Cr Q3 profit; nine-month earnings jump to Rs. 1,725 Cr

NATCO receives CDSCO approval for Semaglutide in India

Zydus receives final approval from USFDA for Ammonium Lactate Cream, 12%

Akums surges in Q3 FY26 with 15% revenue jump, bags key EU & UK nods

FDA nod to Acrotech's new eczema treatment

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion

Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader

Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Interviews

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging

Avantium and Packamama join forces to revolutionise wine packaging with plant-based polymer

Avantium and Packamama join forces to revolutionise wine packaging with plant-based polymer

UPM unveils world’s first carbon-negative, fully recyclable black pigment

UPM unveils world’s first carbon-negative, fully recyclable black pigment

Aptar acquires Brazilian pharma packaging firm Sommaplast

Aptar acquires Brazilian pharma packaging firm Sommaplast